Company Profile

Alish Life Saving Impex Private Limited, founded in 2008, is headquartered in Delhi with a corporate office in Mumbai, India. Pioneering in its field, the company specializes in the manufacture of products dedicated to enhancing the quality of life for cancer and radiation therapy patients. Our organization boasts a comprehensive and integrated product portfolio focused on pharmaceuticals and healthcare, encompassing critical domains such as post-radiation skin care, Oncology, Urology, Neurology, and Nephrology. We are committed to providing innovative solutions and support to improve the well-being of patients in these specialized medical areas.

At ALISH, we believe that if we take care of the present, we inspire a better future. It is this vision towards a disease-free world, a sustainable natural environment and a healthy global population that supports our commitment to ensure the highest quality of products and services our towards offering unparalleled care to our clients, and to the larger community.

ALISH has business interests in Imports and Marketing of Healthcare products and Devices.

Company Growth

ALISH is one of the fastest growing Pharma Marketing Company and It’s products and services portfolio includes.

• Import and Marketing of Medical Devices from USA/ Europe;
• Manufacturing (Under License) and Marketing;

Anti-Cancer Injectables (Chemo Therapy) drugs like (Vivgem 1000mg, 200mg, Vivdoc 120mg, 80mg, 20mg, Vivplant 100mg, 50mg, Vivtax, 260mg, 100mg, 30mg) manufacturing under loan license. Post Radiation Skin Care Lotions and Mouth Sprays for Oncology patients, manufacturing under loan license. In a very short time the company has made tremendous progess. it has achieved annual turnover of millions of INR from 2012-2014.

The company has diversified in a major way in manufacturing and Marketing of various products as shows at Annexure A (List of Products). The company has its marked presence already in major Parts of India. Various Cities/Towns covered are shown at Annexure B (Cities/States Covered). The company has taken over a large marketing set-up, and is presently careering to renowned Hospital all over India such as Army Hospital, Government Hospital, Railways Hospital and Private Hospital. Major customers are shown at Annexure C.

Future Plans

Management of ALISH has major Expansion and Diversification plans chalked out, and venturing fast into manufacturing and distribution of affordable products and devices to individual patients, institutions and organizations. Company intends to import following range of critical products (Under License), from the world leaders in pharma Manufacturing form USA and other advanced countries for marketing in the Indian sub-continent.

• The company has a range of products which includes: Anti-Fungal Injectables , New drugs for Cancer related ailments, Post Radiation skin care products , Gastrology and Nephrology related products.
• The company also plans to start manufacturing Food Supplements and high Protein food items.
• The company has got plans to setup a unit to manufacture Oncology and Nephrology related drugs.

Demand outlook for its various products:

Company sees huge potential in Anti-Cancer drugs, Post Radiation Skin Care/ treatment drugs, Gostro and Nephro drugs. Most of the drugs are being presently imported and hence they are expensive and the price prohibitive for Indian markets. There is a scope for manufacturing of these branded drugs (Under License) in India, which could make them affordable for the masses. There is a huge demand for Food Supplements and High-Protein Food items. India faces severe widespread malnutrition problems. These Food Supplements Could be a great support to daily food and diet.

Exports:

The company is looking at various markets to develops the exports. The regions of interest are Africa, South-East Asia, Middle-East, Sri Lanka, Bangladesh and Nepal. Management is in process to shortlist marketing partners in the above mentioned territories.